Floatz logo

METAMIZOLE

Acute Myeloid Leukemia

Peking University People's HospitalSmall moleculeN/AActive
D
26/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
59/ 100

Competitive context

373 Active assets in the Acute Myeloid Leukemia cohort.

Asset / SponsorPhaseRating
Daunorubicin
Shen yang
Phase 4BB
Idarubicine
Institute of Hematology & Blood Diseases Hospital, China
Phase 4BB
ETOPOSIDE
Memorial Sloan Kettering Cancer Center
Phase 4BB
Mitoxantrone
Institute of Hematology & Blood Diseases Hospital, China
Phase 4BB
FILGRASTIM
City of Hope Medical Center
Phase 4BB

View all 50 →

Same molecule, other indications

METAMIZOLE is also rated in:

post-operative pain, non-human animalDormant
BB
Indicative ·
68 / 100
View asset →
Carcinoma, HepatocellularDormant
BB
Indicative ·
67 / 100
View asset →
Pain ManagementDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →